Empowered Funds LLC lowered its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 11.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,780 shares of the company’s stock after selling 8,139 shares during the period. Empowered Funds LLC’s holdings in Option Care Health were worth $1,976,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the company. Sivik Global Healthcare LLC grew its stake in Option Care Health by 10.0% during the third quarter. Sivik Global Healthcare LLC now owns 110,000 shares of the company’s stock valued at $3,462,000 after acquiring an additional 10,000 shares in the last quarter. Yousif Capital Management LLC grew its stake in Option Care Health by 1.0% in the 3rd quarter. Yousif Capital Management LLC now owns 81,699 shares of the company’s stock worth $2,571,000 after buying an additional 811 shares in the last quarter. Shilanski & Associates Inc. purchased a new position in Option Care Health in the 3rd quarter worth approximately $1,443,000. Financial Gravity Asset Management Inc. purchased a new position in Option Care Health in the 3rd quarter worth approximately $2,258,000. Finally, CIBC Asset Management Inc purchased a new position in Option Care Health in the 3rd quarter worth approximately $214,000. Hedge funds and other institutional investors own 97.63% of the company’s stock.
Option Care Health Trading Down 1.0 %
Shares of OPCH opened at $28.06 on Wednesday. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 2.23 and a beta of 1.17. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.22 and a current ratio of 1.62. Option Care Health, Inc. has a fifty-two week low of $21.52 and a fifty-two week high of $35.87. The firm has a 50 day moving average price of $29.42 and a 200-day moving average price of $31.26.
Wall Street Analyst Weigh In
Separately, Barrington Research boosted their price target on shares of Option Care Health from $37.00 to $38.00 and gave the stock an “outperform” rating in a research note on Friday, October 28th.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.